Pay in 4 interest-free payments of $6.63 Learn more
.png)
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Administered as a once-weekly injection, Wegovy is indicated for adults with a BMI of 30 or higher, or 27 or higher with at least one weight-related condition
[PMID: 30649] PubMed record related to this compound for laboratory literature review
This represents the maximum studied dose in clinical trials
Most of these medications are administered via subcutaneous injection, with dosing frequencies ranging from twice daily to once weekly depending on the specific formulation
Samples were fixed in 3.7% paraformaldehyde (PFA) at 4C for 24 h and then decalcified in 500 mM ethylenediaminetetraacetic acid (EDTA) (pH 7.4, VWR, Pennsylvania, USA) 66
US$ 24.50
US$ 29.36
US$ 29.63
US$ 27.18
